NCT00694343

Brief Summary

The aim of the study is to evaluate the efficacy of Voluven® in the prevention of maternal hypotension in women undergoing spinal anesthesia for cesarean section

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
167

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jun 2008

Geographic Reach
1 country

14 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

June 6, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 10, 2008

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
Last Updated

May 31, 2012

Status Verified

May 1, 2012

Enrollment Period

1.5 years

First QC Date

June 6, 2008

Last Update Submit

May 30, 2012

Conditions

Keywords

Cesarean sectionspinal anesthesiahypotension

Outcome Measures

Primary Outcomes (1)

  • Incidence of hypotension

    Time between induction of spinal anesthesia until delivery

Secondary Outcomes (4)

  • Minimum of systolic blood pressure until delivery

    between induction of anesthesia and delivery

  • Maternal heart rate between induction of anesthesia and delivery

    between induction of anesthesia and delivery

  • Onset and duration of hypotension between induction of anesthesia and delivery

    between induction of anesthesia and delivery

  • Phenylephrine requirements to keep systolic blood pressure equal or higher than 95% of baseline value

    between induction of anesthesia and delivery

Study Arms (2)

Group A

EXPERIMENTAL

500 mL of HES 130/0.4 (6%) and 500 mL Ringer's Lactate Solution

Drug: HES 130/0.4 (6%) in sodium chloride (solution for infusion)

Group B

ACTIVE COMPARATOR

1000 mL Ringer's Lactate solution

Drug: Ringer's Lactate solution

Interventions

500 mL of HES 130/0.4 (6%) and 500 mL Ringer's Lactate Solution

Also known as: Voluven®
Group A

1000 mL Ringer's Lactate solution

Also known as: Ringer's Lactate
Group B

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • elective cesarean section applying spinal anesthesia
  • ≥ week 37 of gestation
  • Singleton pregnancy

You may not qualify if:

  • Suspicion of any hypertensive disease
  • Parturient in labor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (14)

CHU Clermont Ferrand - Hotel Dieu, Service Anesthesie-Reanimation

Clermont-Ferrand, 63003, France

Location

Höpital Louis-Mourier - Service d'Anesthesie

Colombes, 92701, France

Location

Département d'Anesthésie-Réanimation - Centre Hospitalo-Universitaire de Bicêtre

Le Kremlin-Bicêtre, 94275, France

Location

Hopital Jeanne de Flandre, CHU

Lille, 59037, France

Location

CHU Hotel Dieu, Service Anesthesie

Lyon, 69002, France

Location

Hopital Arnaud de Villeneuve - Service Anesthésie-Réanimation

Montpellier, 34295, France

Location

Hopital de l'Archet, Service Anesthesie-Reanimation

Nice, 6200, France

Location

Hopital Caremeau, CHU, Service Anesthesie

Nîmes, 30000, France

Location

Hopital Cochin, Service Anesthesie-Reanimation Chirurgicale

Paris, 75014, France

Location

Hôpital Armand-Trousseau, Service d'anesthésie-réanimation

Paris, 75571, France

Location

Hopital Robert Debre, CHU, Service Anesthesie

Reims, 51100, France

Location

Hopital Hautepierre, CHU, Service Reanimation Chirurgicale

Strasbourg, 6700, France

Location

Hopital Foch,Service Anesthesie

Suresnes, 92150, France

Location

Unité d'anesthésie - Maternité Paule de Viguier

Toulouse, 31059, France

Location

Related Publications (2)

  • Chooi C, Cox JJ, Lumb RS, Middleton P, Chemali M, Emmett RS, Simmons SW, Cyna AM. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database Syst Rev. 2020 Jul 1;7(7):CD002251. doi: 10.1002/14651858.CD002251.pub4.

  • Mercier FJ, Diemunsch P, Ducloy-Bouthors AS, Mignon A, Fischler M, Malinovsky JM, Bolandard F, Aya AG, Raucoules-Aime M, Chassard D, Keita H, Rigouzzo A, Le Gouez A; CAESAR Working Group. 6% Hydroxyethyl starch (130/0.4) vs Ringer's lactate preloading before spinal anaesthesia for Caesarean delivery: the randomized, double-blind, multicentre CAESAR trial. Br J Anaesth. 2014 Sep;113(3):459-67. doi: 10.1093/bja/aeu103. Epub 2014 Jun 26.

MeSH Terms

Conditions

Hypotension

Interventions

Hydroxyethyl Starch DerivativesSodium ChlorideSolutionsHES 130-0.4Ringer's Lactate

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

StarchDietary CarbohydratesCarbohydratesGlucansPolysaccharidesChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium CompoundsPharmaceutical PreparationsCrystalloid SolutionsIsotonic Solutions

Study Officials

  • Frederic Mercier, Professor

    Hôpital Béclère, Service Anesthésie-Réanimation, 157 Rue de la Porte de Trivaux, 92140 Clamart, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2008

First Posted

June 10, 2008

Study Start

June 1, 2008

Primary Completion

December 1, 2009

Study Completion

June 1, 2010

Last Updated

May 31, 2012

Record last verified: 2012-05

Locations